872
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

Biological effects of metal degradation in hip arthroplasties

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 170-193 | Received 13 Feb 2017, Accepted 11 Oct 2017, Published online: 13 Nov 2017

References

  • Ajwani SH, Charalambous CP. 2016. Availability of total knee arthroplasty implants for metal hypersensitivity patients. Knee Surg Relat Res. 28:312–318.
  • Akbar M, Brewer JM, Grant MH. 2011. Effect of chromium and cobalt ions on primary human lymphocytes in vitro. J Immunotoxicol. 8:140–149.
  • Amstutz HC, Campbell P, Kossovsky N, Clarke IC. 1992. Mechanism and clinical significance of wear debris-induced osteolysis. Clin Orthop Relat Res. 276:7–18.
  • Ansari F, Ries MD, Pruitt L. 2016. Effect of processing, sterilization and crosslinking on UHMWPE fatigue fracture and fatigue wear mechanisms in joint arthroplasty. J Mech Behav Biomed Mater. 53:329–340.
  • Athanasou NA. 2016. The pathobiology and pathology of aseptic implant failure. Bone Joint Res. 5:162–168.
  • Australian Orthopaedic Association National Joint Replacement Registry. Annual Report 2014. https://aoanjrr.dmac.adelaide.edu.au/documents/10180/172286/Annual%20Report%202014; [accessed 2016 May 04]. http://www.webcitation.org/6hFfffggD.
  • Azam MQ, McMahon S, Hawdon G, Sankineani SR. 2016. Survivorship and clinical outcome of Birmingham hip resurfacing: a minimum ten years' follow-up. Int Orthop. 40:1–7.
  • Baker-Austin C, Wright MS, Stepanauskas R, McArthur JV. 2006. Co-selection of antibiotic and metal resistance. Trends Microbiol. 14:176–182.
  • Baleani M, Erani P, Bordini B, Zuccheri F, Mąkosa MKD, Pasquale D, Beraudi A, Stea S. 2017. In vivo damage of the head-neck junction in hard-on-hard total hip replacements: effect of femoral head size, metal combination, and 12/14 taper design. Materials (Basel. 10:733).
  • Bedigrew KM, Ruh EL, Zhang Q, Clohisy JC, Barrack RL, Nunley RM. 2012. 2011 Marshall Urist Young Investigator Award: when to release patients to high-impact activities after hip resurfacing. Clin Orthop Relat Res. 470:299–306.
  • Beidelschies MA, Huang H, McMullen MR, Smith MV, Islam AS, Goldberg VM, Chen X, Nagy LE, Greenfield EM. 2008. Stimulation of macrophage TNFalpha production by orthopaedic wear particles requires activation of the ERK1/2/Egr-1 and NF-kappaB pathways but is independent of p38 and JNK. J Cell Physiol. 217:652–666.
  • Berstock JR, Baker RP, Bannister GC, Case CP. 2014. Histology of failed metal-on-metal hip arthroplasty; three distinct sub-types. Hip Int. 24:243–248.
  • Billi F, Benya P, Kavanaugh A, Adams J, Ebramzadeh E, McKellop H. 2012. The John Charnley Award: an accurate and sensitive method to separate, display, and characterize wear debris: part 1: polyethylene particles. Clin Orthop Relat Res. 470:329–338.
  • Billi F, Campbell P. 2010. Nanotoxicology of metal wear particles in total joint arthroplasty: a review of current concepts. J Appl Biomater Biomech. 8:1–6.
  • Bisseling P, Smolders JM, Hol A, van Susante JL. 2015. Metal ion levels and functional results following resurfacing hip arthroplasty versus conventional small-diameter metal-on-metal total hip arthroplasty; a 3 to 5 year follow-up of a randomized controlled trial. J Arthroplasty. 30:61–67.
  • Bosker BH, Ettema HB, Boomsma MF, Kollen BJ, Maas M, Verheyen CC. 2012. High incidence of pseudotumour formation after large-diameter metal-on-metal total hip replacement: a prospective cohort study. J Bone Joint Surg Br. 94:755–761.
  • Bosker BH, Ettema HB, van Rossum M, Boomsma MF, Kollen BJ, Maas M, Verheyen CC. 2015. Pseudotumor formation and serum ions after large head metal-on-metal stemmed total hip replacement. Risk factors, time course and revisions in 706 hips. Arch Orthop Trauma Surg. 135:417–425.
  • Bowsher JG, Hussain A, Williams PA, Shelton JC. 2006. Metal-on-metal hip simulator study of increased wear particle surface area due to ‘severe’ patient activity. Proc Inst Mech Eng H. 220:279–287.
  • Brach Del Prever EM, Bistolfi A, Bracco P, Costa L. 2009. UHMWPE for arthroplasty: past or future? J Orthopaed Traumatol. 10:1–8.
  • Bradberry SM, Wilkinson JM, Ferner RE. 2014. Systemic toxicity related to metal hip prostheses. Clin Toxicol (Phila). 52:837–847.
  • Brand RA. 2010. 50 Years ago in CORR: complications in replacement arthroplasty of the hip; experience with 68 additional cases Howard Mendelsohn, MD and Bernard N. Becker, MD CORR. 1955;6:48–53. Clin Orthop Relat Res. 468:2550–2552.
  • Bravo D, Wagner ER, Larson DR, Davis MP, Pagnano MW, Sierra RJ. 2016. No increased risk of knee arthroplasty failure in patients with positive skin patch testing for metal hypersensitivity: a matched cohort study. J Arthroplasty. 31:1717–1721.
  • Brewster DH, Stockton DL, Reekie A, Ashcroft GP, Howie CR, Porter DE, Black RJ. 2013. Risk of cancer following primary total hip replacement or primary resurfacing arthroplasty of the hip: a retrospective cohort study in Scotland. Br J Cancer. 108:1883–1890.
  • Briggs TW, Hanna SA, Kayani B, Tai S, Pollock RC, Cannon SR, Blunn GW, Carrington RW. 2015. Metal-on-polyethylene versus metal-on-metal bearing surfaces in total hip arthroplasty: a prospective randomised study investigating metal ion levels and chromosomal aberrations in peripheral lymphocytes. Bone Joint J. 97-B:1183–1191.
  • Brulefert K, Córdova LA, Brulin B, Faucon A, Hulin P, Nedellec S, Gouin F, Passuti N, Ishow E, Heymann D. 2016. Pro-osteoclastic in vitro effect of polyethylene-like nanoparticles: involvement in the pathogenesis of implant aseptic loosening. J Biomed Mater Res A. 104:2649–2657.
  • Bursch W, Karwan A, Mayer M, Dornetshuber J, Frohwein U, Schulte-Hermann R, Fazi B, Di Sano F, Piredda L, Piacentini M, et al. 2008. Cell death and autophagy: cytokines, drugs, and nutritional factors. Toxicology. 254:147–157.
  • Cadosch D, Chan E, Gautschi OP, Filgueira L. 2009. Metal is not inert: role of metal ions released by biocorrosion in aseptic loosening–current concepts. J Biomed Mater Res. 91:1252–1262.
  • Cadossi M, Chiarello E, Savarino L, Mazzotti A, Tedesco G, Greco M, Giannini S. 2014. Fast growing pseudotumour in a hairdresser after metal-on-metal hip resurfacing: a case report. Eur Rev Med Pharmacol Sci. 18:29–33.
  • Cadossi M, Tedesco G, Savarino L, Baldini N, Mazzotti A, Greco M, Giannini S. 2014. Effect of acetabular cup design on metal ion release in two designs of metal-on-metal hip resurfacing. J Biomed Mater Res B Appl Biomater. 102:1595–1601.
  • Caicedo MS, Samelko L, McAllister K, Jacobs JJ, Hallab NJ. 2013. Increasing both CoCrMo-alloy particle size and surface irregularity induces increased macrophage inflammasome activation in vitro potentially through lysosomal destabilization mechanisms. J Orthop Res. 31:1633–1642.
  • Caicedo MS, Solver E, Coleman L, Jacobs JJ, Hallab NJ. 2017. Females with unexplained joint pain following total joint arthroplasty exhibit a higher rate and severity of hypersensitivity to implant metals compared with males: implications of sex-based bioreactivity differences. J Bone Joint Surg Am. 99:621–628.
  • Campbell P, Ebramzadeh E, Nelson S, Takamura K, De Smet K, Amstutz HC. 2010. Histological features of pseudotumor-like tissues from metal-on-metal hips. Clin Orthop Relat Res. 468:2321–2327.
  • Campbell P, Ma S, Yeom B, McKellop H, Schmalzried TP, Amstutz HC. 1995. Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res. 29:127–131.
  • Campbell PA, Kung MS, Hsu AR, Jacobs JJ. 2014. Do retrieval analysis and blood metal measurements contribute to our understanding of adverse local tissue reactions? Clin Orthop Relat Res. 472:3718–3727.
  • Case CP, Langkamer VG, James C, Palmer MR, Kemp AJ, Heap PF, Solomon L. 1994. Widespread dissemination of metal debris from implants. J Bone Joint Surg Br. 76:701–712.
  • Case CP, Langkamer VG, Lock RJ, Perry MJ, Palmer MR, Kemp AJ. 2000. Changes in the proportions of peripheral blood lymphocytes in patients with worn implants. J Bone Joint Surg Br. 82:748–754.
  • Case CP. 2001. Chromosomal changes after surgery for joint replacement. J Bone Joint Surg Br. 83:1093–1095.
  • Catelas I, Lehoux EA, Hurda I, Baskey SJ, Gala L, Foster R, Kim PR, Beaule PE. 2015. Do patients with a failed metal-on-metal hip implant with a pseudotumor present differences in their peripheral blood lymphocyte subpopulations? Clin Orthop Relat Res. 473:3903–3914.
  • Chang EY, McAnally JL, Van Horne JR, Van Horne JG, Wolfson T, Gamst A, Chung CB. 2013. Relationship of plasma metal ions and clinical and imaging findings in patients with ASR XL metal-on-metal total hip replacements. J Bone Joint Surg Am. 95:2015–2020.
  • Charnley J. 1970. Total hip replacement by low-friction arthroplasty. Clin Orthop Relat Res. 72:7–21.
  • Christensen TJ, Samant SA, Shin AY. 2017. Making sense of metal allergy and hypersensitivity to metallic implants in relation to hand surgery. J Hand Surg Am. 42:737–746.
  • Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL. 2014. Toxicology-based cancer causation analysis of CoCr-containing hip implants: a quantitative assessment of genotoxicity and tumorigenicity studies. J Appl Toxicol. 34:939–967.
  • Christo SN, Diener KR, Bachhuka A, Vasilev K, Hayball JD. 2015. Innate immunity and biomaterials at the nexus: friends or foes. Biomed Res Int. 2015:342304.
  • Cobelli N, Scharf B, Crisi GM, Hardin J, Santambrogio L. 2011. Mediators of the inflammatory response to joint replacement devices. Nat Rev Rheumatol. 7:600–608.
  • Coleman RF, Herrington J, Scales JT. 1973. Concentration of wear products in hair, blood, and urine after total hip replacement. Br Med J. 1:527–529.
  • Colognato R, Bonelli A, Ponti J, Farina M, Bergamaschi E, Sabbioni E, Migliore L. 2008. Comparative genotoxicity of cobalt nanoparticles and ions on human peripheral leukocytes in vitro. Mutagenesis. 23:377–382.
  • Corbo C, Molinaro R, Parodi A, Toledano Furman NE, Salvatore F, Tasciotti E. 2016. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine (Lond). 11:81–100.
  • Davies AP, Sood A, Lewis AC, Newson R, Learmonth ID, Case CP. 2005. Metal-specific differences in levels of DNA damage caused by synovial fluid recovered at revision arthroplasty. J Bone Joint Surg Br. 87:1439–1444.
  • Davis DL, Morrison JJ. 2016. Hip arthroplasty pseudotumors: pathogenesis, imaging, and clinical decision making. J Clin Imaging Sci. 6:17. eCollection 2016.
  • De Haan R, Pattyn C, Gill HS, Murray DW, Campbell PA, De Smet K. 2008. Correlation between inclination of the acetabular component and metal ion levels in metal-on-metal hip resurfacing replacement. J Bone Joint Surg Br. 90:1291–1297.
  • De Pasquale D, Stea S, Squarzoni S, Bordini B, Amabile M, Catalani S, Apostoli P, Toni A. 2014. Metal-on-metal hip prostheses: correlation between debris in the synovial fluid and levels of cobalt and chromium ions in the bloodstream. Int Orthop. 38:469–475.
  • Descotes J. 2004. Importance of immunotoxicity in safety assessment: a medical toxicologist's perspective. Toxicol Lett. 149:103–108.
  • Desy NM, Bergeron SG, Petit A, Huk OL, Antoniou J. 2011. Surgical variables influence metal ion levels after hip resurfacing. Clin Orthop Relat Res. 469:1635–1641.
  • Doherty AT, Howell RT, Ellis LA, Bisbinas I, Learmonth ID, Newson R, Case CP. 2001. Increased chromosome translocations and aneuploidy in peripheral blood lymphocytes of patients having revision arthroplasty of the hip. J Bone Joint Surg Br. 83:1075–1081.
  • Doorn PF, Campbell PA, Worrall J, Benya PD, McKellop HA, Amstutz HC. 1998. Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res. 42:103–111.
  • Drummond J, Tran P, Fary C. 2015. Metal-on-metal hip arthroplasty: a review of adverse reactions and patient management. J Funct Biomater. 6:486–499.
  • Duggan PJ, Burke CJ, Saha S, Moonim M, George M, Desai A, Houghton R. 2013. Current literature and imaging techniques of aseptic lymphocyte-dominated vasculitis-associated lesions (ALVAL). Clin Radiol. 68:1089–1096.
  • Eastwood SE, John A, Jones SA, Hodgson H, Mason D, Waddington R, Wei X. 2015. Osteoclastogenesis-related cytokines and peri-prosthetic osteolysis in revision metal-on-metal total hip replacements. Hip Int. 25:355–360.
  • Engh CA, MacDonald SJ, Sritulanondha S, Korczak A, Naudie D, Engh C. 2014. Metal ion levels after metal-on-metal total hip arthroplasty: a five-year, prospective randomized trial. J Bone Joint Surg Am. 96:448–455.
  • Esposito CI, Wright TM, Goodman SB, Berry DJ. 2014. What is the trouble with trunnions? Clin Orthop Relat Res. 472:3652–3658.
  • Estey MP, Diamandis EP, Van Der Straeten C, Tower SS, Hart AJ, Moyer TP. 2013. Cobalt and chromium measurement in patients with metal hip prostheses. Clin Chem. 59:880–886.
  • Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY. 2004. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am. 86-A:963–974.
  • European Commission. 2014. Scientific Committee on Emerging Newly Identified Health Risks (SCENHIR). Final Opinion on: The safety of metal-on-metal joint replacements with a particular focus on hip implants. http://www.webcitation.org/6hFeevoLy.
  • Evans EM, Freeman MA, Miller AJ, Vernon-Roberts B. 1974. Metal sensitivity as a cause of bone necrosis and loosening of the prosthesis in total joint replacement. J Bone Joint Surg Br. 56-B:626–642.
  • Feng PH, Huang YL, Chuang KJ, Chen KY, Lee KY, Ho SC, Bien MY, Yang YL, Chuang HC. Taiwan CardioPulmonary Research Group. 2015. Dysfunction of methionine sulfoxide reductases to repair damaged proteins by nickel nanoparticles. Chem Biol Interact. 236:82–89.
  • Food and Drug Administration (FDA). 1999. Center for devices and radiological health. Guidance for industry and FDA reviewers. Immunotoxicity Testing Guidance; p. 1–16. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm080627; [accessed 2016 May 04]. http://www.webcitation.org/6hFeFD4sa).
  • Fujishiro T, Moojen DJ, Kobayashi N, Dhert WJ, Bauer TW. 2011. Perivascular and diffuse lymphocytic inflammation are not specific for failed metal-on-metal hip implants. Clin Orthop Relat Res. 469:1127–1133.
  • Gallo J, Goodman SB, Konttinen YT, Raska M. 2013. Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty. Innate Immun. 19:213–224.
  • Gallo J, Raska M, Konttinen YT, Nich C, Goodman SB. 2014. Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview. J Long Term Eff Med Implants. 24:297–317.
  • Galluzzi L, Kepp O, Kroemer G. 2009. RIP kinases initiate programmed necrosis. J Mol Cell Biol. 1:8–10.
  • Gill HS, Grammatopoulos G, Adshead S, Tsialogiannis E, Tsiridis E. 2012. Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends Mol Med. 18:145–155.
  • Glyn-Jones S, Pandit H, Kwon YM, Doll H, Gill HS, Murray DW. 2009. Risk factors for inflammatory pseudotumour formation following hip resurfacing. J Bone Joint Surg Br. 91:1566–1574.
  • Glyn-Jones S, Roques A, Taylor A, Kwon YM, McLardy-Smith P, Gill HS, Walter W, Tuke M, Murray D. 2011. The in vivo linear and volumetric wear of hip resurfacing implants revised for pseudotumor. J Bone Joint Surg Am. 93:2180–2188.
  • Goodman SB, Gibon E, Yao Z. 2013. The basic science of periprosthetic osteolysis. Instr Course Lect. 62:201–206.
  • Goodman SB. 2007. Wear particles, periprosthetic osteolysis and the immune system. Biomaterials. 28:5044–5048.
  • Grammatopoulos G, Pandit H, Kamali A, Maggiani F, Glyn-Jones S, Gill HS, Murray DW, Athanasou N. 2013. The correlation of wear with histological features after failed hip resurfacing arthroplasty. J Bone Joint Surg Am. 95:e81.
  • Grammatopoulos G, Pandit H, Kwon YM, Gundle R, McLardy-Smith P, Beard DJ, Murray DW, Gill HS. 2009. Hip resurfacings revised for inflammatory pseudotumour have a poor outcome. J Bone Joint Surg Br. 91:1019–1024.
  • Grammatopoulos G, Pandit H, Oxford Hip and Knee Group, Murray DW, Gill HS. 2010. The relationship between head-neck ratio and pseudotumour formation in metal-on-metal resurfacing arthroplasty of the hip. J Bone Joint Surg Br. 92:1527–1534.
  • Granchi D, Cenni E, Ciapetti G, Savarino L, Stea S, Gamberini S, Gori A, Pizzoferrato A. 1998. Cell death induced by metal ions: necrosis or apoptosis? J Mater Sci Mater Med. 9:31–37.
  • Granchi D, Cenni E, Giunti A, Baldini N. 2012. Metal hypersensitivity testing in patients undergoing joint replacement: a systematic review. J Bone Joint Surg Br. 94:1126–1134.
  • Granchi D, Cenni E, Tigani D, Trisolino G, Baldini N, Giunti A. 2008. Sensitivity to implant materials in patients with total knee arthroplasties. Biomaterials. 29:1494–1500.
  • Granchi D, Ciapetti G, Savarino L, Cavedagna D, Donati ME, Pizzoferrato A. 1996. Assessment of metal extract toxicity on human lymphocytes cultured in vitro. J Biomed Mater Res. 31:183–191.
  • Granchi D, Ciapetti G, Stea S, Cavedagna D, Bettini N, Bianco T, Fontanesi G, Pizzoferrato A. 1995. Evaluation of several immunological parameters in patients with aseptic loosening of hip arthroplasty. Chir Org Mov. 80:399–408.
  • Granchi D, Pellacani A, Spina M, Cenni E, Savarino LM, Baldini N, Giunti A. 2006. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis. J Bone Joint Surg Am. 88:1501–1509.
  • Granchi D, Verri E, Ciapetti G, Savarino L, Cenni E, Gori A, Pizzoferrato A. 1998. Effects of chromium extract on cytokine release by mononuclear cells. Biomaterials. 19:283–291.
  • Grosse S, Haugland HK, Lilleng P, Ellison P, Hallan G, Høl PJ. 2015. Wear particles and ions from cemented and uncemented titanium-based hip prostheses—a histological and chemical analysis of retrieval material. J Biomed Mater Res B Appl Biomater. 103:709–717.
  • Gustafson K, Jakobsen SS, Lorenzen ND, Thyssen JP, Johansen JD, Bonefeld CM, Stilling M, Baad-Hansen T, Soballe K. 2014. Metal release and metal allergy after total hip replacement with resurfacing versus conventional hybrid prosthesis. Acta Orthop. 85:348–354.
  • Hallab N, Merritt K, Jacobs J. 2001. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am. 83-A:428–436.
  • Hart AJ, Muirhead-Allwood S, Porter M, Matthies A, Ilo K, Maggiore P, Underwood R, Cann P, Cobb J, Skinner JA. 2013. Which factors determine the wear rate of large-diameter metal-on-metal hip replacements? Multivariate analysis of two hundred and seventy-six components. J Bone Joint Surg Am. 95:678–685.
  • Hart AJ, Quinn PD, Sampson B, Sandison A, Atkinson KD, Skinner JA, Powell JJ, Mosselmans JF. 2010. The chemical form of metallic debris in tissues surrounding metal-on-metal hips with unexplained failure. Acta Biomater. 6:4439–4446.
  • Hart AJ, Skinner JA, Winship P, Faria N, Kulinskaya E, Webster D, Muirhead-Allwood S, Aldam CH, Anwar H, Powell JJ. 2009. Circulating levels of cobalt and chromium from metal-on-metal hip replacement are associated with CD8+ T-cell lymphopenia. J Bone Joint Surg Br. 91:835–842.
  • Hartmann A, Hannemann F, Lutzner J, Seidler A, Drexler H, Gunther KP, Schmitt J. 2013. Metal ion concentrations in body fluids after implantation of hip replacements with metal-on-metal bearing-systematic review of clinical and epidemiological studies. PLoS One. 8:e70359.
  • Harvie P, Giele H, Fang C, Ansorge O, Ostlere S, Gibbons M, Whitwell D. 2008. The treatment of femoral neuropathy due to pseudotumour caused by metal-on-metal resurfacing arthroplasty. Hip Int. 18:313–320.
  • Hasegawa M, Iino T, Sudo A. 2016. Immune response in adverse reactions to metal debris following metal-on-metal total hip arthroplasty. BMC Musculoskelet Disord. 17:221.
  • Haughom BD, Erickson BJ, Hellman MD, Jacobs JJ. 2015. Do complication rates differ by gender after metal-on-metal hip resurfacing arthroplasty? A systematic review. Clin Orthop Relat Res. 473:2521–2529.
  • Haynes DR, Crotti TN, Potter AE, Loric M, Atkins GJ, Howie DW, Findlay DM. 2001. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg Br. 83:902–911.
  • Hayot M, Rodriguez J, Vernus B, Carnac G, Jean E, Allen D, Goret L, Obert P, Candau R, Bonnieu A. 2011. Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli. Mol Cell Endocrinol. 332:38–47.
  • Hirayama T, Tamaki Y, Takakubo Y, Iwazaki K, Sasaki K, Ogino T, Goodman SB, Konttinen YT, Takagi M. 2011. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles. J Orthop Res. 29:984–992.
  • Hjorth MH, Stilling M, Soballe K, Bolvig LH, Thyssen JP, Mechlenburg I, Jakobsen SS. 2016. No association between pseudotumors, high serum metal-ion levels and metal hypersensitivity in large-head metal-on-metal total hip arthroplasty at 5–7-year follow-up. Skeletal Radiol. 45:115–125.
  • Holland P, Santini AJ, Davidson JS, Pope JA. 2013. Five year survival analysis of an oxidised zirconium total knee arthroplasty. Knee. 20:384–387.
  • Huang Z, Ma T, Ren PG, Smith RL, Goodman SB. 2010. Effects of orthopedic polymer particles on chemotaxis of macrophages and mesenchymal stem cells. J Biomed Mater Res A. 94:1264–1269.
  • Huk OL, Catelas I, Mwale F, Antoniou J, Zukor DJ, Petit A. 2004. Induction of apoptosis and necrosis by metal ions in vitro. J Arthroplasty. 19:84–87.
  • Hur CI, Yoon TR, Cho SG, Song EK, Seon JK. 2008. Serum ion level after metal-on-metal THA in patients with renal failure. Clin Orthop Relat Res. 466:696–699.
  • Hutt J, Lavigne M, Lungu E, Belzile E, Morin F, Vendittoli PA. 2016. Comparison of whole-blood metal ion levels among four types of large-head, metal-on-metal total hip arthroplasty implants: a concise follow-up, at five years, of a previous report. J Bone Joint Surg Am. 98:257–266.
  • Ingham E, Fisher J. 2005. The role of macrophages in osteolysis of total joint replacement. Biomaterials. 26:1271–1286.
  • ISO/TS 10993-20:2006 Biological evaluation of medical devices – part 20: principles and methods for immunotoxicology testing of medical devices; 2006; p. 1–24.
  • Jack CM, Walter WL, Shimmin AJ, Cashman K, de Steiger RN. 2013. Large diameter metal on metal articulations. Comparison of total hip arthroplasty and hip resurfacing arthroplasty. J Arthroplasty. 28:650–653.
  • Jacobs JJ, Urban RM, Hallab NJ, Skipor AK, Fischer A, Wimmer MA. 2009. Metal-on-metal bearing surfaces. J Am Acad Orthop Surg. 17:69–76.
  • Jamsen E, Kouri VP, Olkkonen J, Cor A, Goodman SB, Konttinen YT, Pajarinen J. 2014. Characterization of macrophage polarizing cytokines in the aseptic loosening of total hip replacements. J Orthop Res. 32:1241–1246.
  • Jasty M, Bragdon C, Jiranek W, Chandler H, Maloney W, Harris WH. 1994. Etiology of osteolysis around porous-coated cementless total hip arthroplasties. Clin Orthop Relat Res. 308:111–126.
  • Jomova K, Valko M. 2011. Advances in metal-induced oxidative stress and human disease. Toxicology. 283:65–87.
  • Kaluđerović MR, Mojic M, Schreckenbach JP, Maksimovic-Ivanic D, Graf HL, Mijatovic S. 2014. A key role of autophagy in osteoblast differentiation on titanium-based dental implants. Cells Tissues Organs. 200:265–277.
  • Keegan GM, Learmonth ID, Case CP. 2007. Orthopaedic metals and their potential toxicity in the arthroplasty patient: a review of current knowledge and future strategies. J Bone Joint Surg Br. 89:567–573.
  • Keegan GM, Learmonth ID, Case CP. 2008. A systematic comparison of the actual, potential, and theoretical health effects of cobalt and chromium exposures from industry and surgical implants. Crit Rev Toxicol. 38:645–674.
  • Kerr JF, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257.
  • Konttinen YT, Pajarinen J, Takakubo Y, Gallo J, Nich C, Takagi M, Goodman SB. 2014. Macrophage polarization and activation in response to implant debris: influence by “particle disease” and “ion disease”. J Long Term Eff Med Implants. 24:267–281.
  • Kou PM, Babensee JE. 2011. Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. J Biomed Mater Res A. 96:239–260.
  • Krenn V, Kretzer JP, Thomas P, Thomsen M, Usbeck S, Scheuber L, Boettner F, Rüther W, Schulz S, Zustin J, et al. 2013. Update on endoprosthesis pathology: particle algorithm for particle identification in the SLIM. Semin Arthroplasty. 24:265–275.
  • Krenn V, Morawietz L, Perino G, Kienapfel H, Ascherl R, Hassenpflug GJ, Thomsen M, Thomas P, Huber M, Kendoff D, et al. 2014. Revised histopathological consensus classification of joint implant related pathology. Pathol Res Pract. 210:779–786.
  • Krenn V, Perino G. 2017. Histological diagnosis of implant-associated pathologies. Berlin, Germany: Springer Verlag.
  • Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, et al. 2009. Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death Differ. 16:3–11.
  • Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. 2009. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 467:2606–2612.
  • Kurtz SM, Lau EC, Ong KL, Adler EM, Kolisek FR, Manley MT. Forthcoming. Which clinical and patient factors influence the national economic burden of hospital readmissions after total joint arthroplasty? Clin Orthop Relat Res. [accessed 2017 Jan 20]. DOI: 10.1007/s11999-017-5244-6
  • Kwon YM, Glyn-Jones S, Simpson DJ, Kamali A, McLardy-Smith P, Gill HS, Murray DW. 2010. Analysis of wear of retrieved metal-on-metal hip resurfacing implants revised due to pseudotumours. J Bone Joint Surg Br. 92:356–361.
  • Kwon YM, Ostlere SJ, McLardy-Smith P, Athanasou NA, Gill HS, Murray DW. 2011. “Asymptomatic” pseudotumors after metal-on-metal hip resurfacing arthroplasty: prevalence and metal ion study”. J Arthroplasty. 26:511–518.
  • Lähdeoja T, Pajarinen J, Kouri VP, Sillat T, Salo J, Konttinen YT. 2010. Toll-like receptors and aseptic loosening of hip endoprosthesis—a potential to respond against danger signals? J Orthop Res. 28:184–190.
  • Lainiala O, Reito A, Jämsä P, Eskelinen A. 2017. Mild or moderate renal insufficiency does not increase circulating levels of cobalt and chromium in patients with metal-on-metal hip arthroplasty. Bone Joint J. 99-B:1147–1152.
  • Landgraeber S, Jäger M, Jacobs JJ, Hallab NJ. 2014. The pathology of orthopedic implant failure is mediated by innate immune system cytokines. Mediators Inflamm. 2014:185150.
  • Langton DJ, Jameson SS, Joyce TJ, Hallab NJ, Natu S, Nargol AV. 2010. Early failure of metal-on-metal bearings in hip resurfacing and large-diameter total hip replacement: a consequence of excess wear. J Bone Joint Surg Br. 92:38–46.
  • Langton DJ, Joyce TJ, Jameson SS, Lord J, Van Orsouw M, Holland JP, Nargol AV, De Smet KA. 2011. Adverse reaction to metal debris following hip resurfacing: the influence of component type, orientation and volumetric wear. J Bone Joint Surg Br. 93:164–171.
  • Lavernia CJ, Iacobelli DA, Brooks L, Villa JM. 2015. The cost-utility of total hip arthroplasty: earlier intervention, improved economics. J Arthroplasty. 30:945–949.
  • Lawrence H, Mawdesley AE, Holland JP, Kirby JA, Deehan DJ, Tyson-Capper AJ. 2016. Targeting Toll-like receptor 4 prevents cobalt-mediated inflammation. Oncotarget. 7:7578–7585.
  • Lee YK, Yoon BH, Choi YS, Jo WL, Ha YC, Koo KH. 2016. Metal on metal or ceramic on ceramic for cementless total hip arthroplasty: a meta-analysis. J Arthroplasty. 31:2637–2645.
  • Leyssens L, Vinck B, Van Der Straeten C, Wuyts F, Maes L. 2017. Cobalt toxicity in humans-A review of the potential sources and systemic health effects. Toxicology. 387:43–56.
  • Lohmann CH, Hameister R, Singh G. 2017. Allergies in orthopaedic and trauma surgery. Orthop Traumatol Surg Res. 103:S75–S81.
  • Lopes VR, Loitto V, Audinot JN, Bayat N, Gutleb AC, Cristobal S. 2016. Dose-dependent autophagic effect of titanium dioxide nanoparticles in human HaCaT cells at non-cytotoxic levels. J Nanobiotechnol. 14:22–016-0174-0.
  • Loyo E, Jara LJ, Lopez PD, Puig AC. 2012. Autoimmunity in connection with a metal implant: a case of autoimmune/autoinflammatory syndrome induced by adjuvants. Auto Immun Highlights. 4:33–38.
  • Lundqvist M. 2013. Nanoparticles: tracking protein corona over time. Nat Nanotechnol. 8:701–702.
  • Lützner J, Hartmann A, Dinnebier G, Spornraft-Ragaller P, Hamann C, Kirschner S. 2013. Metal hypersensitivity and metal ion levels in patients with coated or uncoated total knee arthroplasty: a randomised controlled study. Int Orthop. 37:1925–1931.
  • Machado C, Appelbe A, Wood R. 2012. Arthroprosthetic cobaltism and cardiomyopathy. Heart Lung Circ. 21:759–760.
  • Madathil BK, Lin Q, Hew CL, Mohanty M. 2010. Hypoxia-like effect of cobalt chromium alloy micro particles on fibroblasts in vitro. J Orthop Res. 28:1360–1367.
  • Madl AK, Kovochich M, Liong M, Finley BL, Paustenbach DJ, Oberdorster G. 2015b. Toxicology of wear particles of cobalt–chromium alloy metal-on-metal hip implants. Part II: importance of physicochemical properties and dose in animal and in vitro studies as a basis for risk assessment. Nanomedicine. 11:1285–1298.
  • Madl AK, Liong M, Kovochich M, Finley BL, Paustenbach DJ, Oberdorster G. 2015a. Toxicology of wear particles of cobalt–chromium alloy metal-on-metal hip implants. Part I: physicochemical properties in patient and simulator studies. Nanomedicine. 11:1201–1215.
  • Magone K, Luckenbill D, Goswami T. 2015. Metal ions as inflammatory initiators of osteolysis. Arch Orthop Trauma Surg. 135:683–695.
  • Mahendra G, Pandit H, Kliskey K, Murray D, Gill HS, Athanasou N. 2009. Necrotic and inflammatory changes in metal-on-metal resurfacing hip arthroplasties. Acta Orthop. 80:653–659.
  • Makela KT, Visuri T, Pulkkinen P, Eskelinen A, Remes V, Virolainen P, Junnila M, Pukkala E. 2012. Risk of cancer with metal-on-metal hip replacements: population based study. BMJ. 345:e4646.
  • Maloney WJ, Smith RL, Schmalzried TP, Chiba J, Huene D, Rubash H. 1995. Isolation and characterization of wear particles generated in patients who have had failure of a hip arthroplasty without cement. J Bone Joint Surg Am. 77:1301–1310.
  • Maloney WJ, Sun DH, Nakashima Y, James R, Smith RL. 1998. Effects of serum protein opsonization on cytokine release by titanium-alloy particles. J Biomed Mater Res. 41:371–376.
  • Maradit-Kremers H, Larson DR, Crowson CS, Kremers WK, Washington RE, Steiner CA, Jiranek WA, Berry DJ. 2015. Prevalence of total hip and knee replacement in the United States. J Bone Joint Surg Am. 97:1386–1397.
  • Mathew MT, Runa MJ, Laurent M, Jacobs JJ, Rocha LA, Wimmer MA. 2011. Tribocorrosion behavior of CoCrMo alloy for hip prosthesis as a function of loads: a comparison between two testing systems. Wear. 271:1210–1219.
  • Mathiesen EB, Ahlbom A, Bermann G, Lindgren JU. 1995. Total hip replacement and cancer. A cohort study. J Bone Joint Surg Br. 77:345–350.
  • Mattei L, DiPuccio F, Piccigallo B, Ciulli E. 2011. Lubrication and wear modeling of artificial hip joints: a review. Tribology Int. 44:532–549.
  • Maurer-Ertl W, Friesenbichler J, Holzer LA, Leitner L, Ogris K, Maier M, Leithner A. 2017. Recall of the ASR XL head and hip resurfacing systems. Orthopedics. 40:e340–e347.
  • McKee GK, Watson-Farrar J. 1966. Replacement of arthritic hips by the McKee-Farrar prosthesis. J Bone Joint Surg Br. 48:245–259.
  • McMinn D, Treacy R, Lin K, Pynsent P. 1996. Metal on metal surface replacement of the hip. Experience of the McMinn prosthesis. Clin Orthop Relat Res. 329 Suppl:S89–S98.
  • Merritt K, Rodrigo J. 1996. Immune response to synthetic materials. Sensitization of patients receiving orthopaedic implants. Clin Orthop Relat Res. 326:71–79.
  • MHRA-Medical device alert, MDA/2010/033. Issued: 22 April 2010 at 14:00. http://www.jisrf.org/pdfs/mediacl-device-alert.pdf; [accessed 2016 May 04]. http://www.webcitation.org/6hFfoOh2q.
  • MHRA-Medical device alert, MDA/2012/036. Issued: 25 June 2012 at 11:00. https://assets.digital.cabinet-office.gov.uk/media/5485abf6ed915d4c10000273/con155767.pdf; [accessed 2016 May 04]. http://www.webcitation.org/6hFerPrzw.
  • MHRA-Medical Device Alert, MDA/2015/024. Issued: 25 June 2015 at 14:00. https://assets.digital.cabinet-office.gov.uk/media/558bf580e5274a1559000002/MDA-2015-024.pdf; [accessed 2016 May 04]. http://www.webcitation.org/6hFelBb7v.
  • Middleton S, Toms A. 2016. Allergy in total knee arthroplasty: a review of the facts. Bone Joint J. 98-B:437–441.
  • Miller RA, Ro JY, Schwartz MR. 2017. Adverse tissue reactions after total hip arthroplasty. Ann Diagn Pathol. 27:83–87.
  • Mistry JB, Chughtai M, Elmallah RK, Diedrich A, Le S, Thomas M, Mont MA. 2016. Trunnionosis in total hip arthroplasty: a review. J Orthop Traumatol. 17:1–6.
  • Mittal S, Revell M, Barone F, Hardie DL, Matharu GS, Davenport AJ, Martin RA, Grant M, Mosselmans F, Pynsent P, et al. 2013. Lymphoid aggregates that resemble tertiary lymphoid organs define a specific pathological subset in metal-on-metal hip replacements. PLoS One. 8:e63470.
  • Morlock MM, Bishop N, Zustin J, Hahn M, Ruther W, Amling M. 2008. Modes of implant failure after hip resurfacing: morphological and wear analysis of 267 retrieval specimens. J Bone Joint Surg Am. 3:89–95.
  • Mostardi RA, Kovacik MW, Ramsier RD, Bender ET, Finefrock JM, Bear TF, Askew MJ. 2010. A comparison of the effects of prosthetic and commercially pure metals on retrieved human fibroblasts: the role of surface elemental composition. Acta Biomater. 6:702–707.
  • Münch HJ, Jacobsen SS, Olesen JT, Menne T, Soballe K, Johansen JD, Thyssen JP. 2015. The association between metal allergy, total knee arthroplasty, and revision: study based on the Danish Knee Arthroplasty Register. Acta Orthop. 86:378–383.
  • Munir S, Oliver RA, Zicat B, Walter WL, Walter WK, Walsh WR. 2016. The histological and elemental characterisation of corrosion particles from taper junctions. Bone Joint Res. 5:370–378.
  • Nakamura S, Yasunaga Y, Ikuta Y, Shimogaki K, Hamada N, Takata N. 1997. Autoantibodies to red cells associated with metallosis—a case report. Acta Orthop Scand. 68:495–496.
  • Nakano N, Volpin A, Bartlett J, Khanduja V. 2017. Management guidelines for metal-on-metal hip resurfacing arthroplasty: a strategy on followup. Indian J Orthop. 51:414–420.
  • Nam D, Li K, Riegler V, Barrack RL. 2016. Patient-reported metal allergy: a risk factor for poor outcomes after total joint arthroplasty? J Arthroplasty. 31:1910–1915.
  • National Joint Registry for England, Wales and Northern Ireland. 11th Annual Report 2014. http://www.njrreports.org.uk/Portals/0/PDFdownloads/NJR 11th Annual Report 2014.pdf.
  • Natu S, Sidaginamale RP, Gandhi J, Langton DJ, Nargol AV. 2012. Adverse reactions to metal debris: histopathological features of periprosthetic soft tissue reactions seen in association with failed metal on metal hip arthroplasties. J Clin Pathol. 65:409–418.
  • Nawabi DH, Nassif NA, Do HT, Stoner K, Elpers M, Su EP, Wright T, Potter HG, Padgett DE. 2014. What causes unexplained pain in patients with metal-on metal hip devices? A retrieval, histologic, and imaging analysis. Clin Orthop Relat Res. 472:543–554.
  • Neagu M, Piperigkou Z, Karamanou K, Engin AB, Docea AO, Constantin C, Negrei C, Nikitovic D, Tsatsakis A. 2017. Protein bio-corona: critical issue in immune nanotoxicology. Arch Toxicol. 91:1031–1048.
  • Newman JM, Szubski CR, Barsoum WK, Higuera CA, Molloy RM, Murray TG. 2017. Day of surgery affects length of stay and charges in primary total hip and knee arthroplasty. J Arthroplasty. 32:11–15.
  • Nich C, Goodman SB. 2014. The role of macrophages in the biological reaction to wear debris from joint replacements. J Long Term Eff Med Implants. 24:259–265.
  • Nich C, Takakubo Y, Pajarinen J, Ainola M, Salem A, Sillat T, Rao AJ, Raska M, Tamaki Y, Takagi M, et al. 2013. Macrophages-key cells in the response to wear debris from joint replacements. J Biomed Mater Res A. 101:3033–3045.
  • Novak CC, Hsu AR, Della Valle CJ, Skipor AK, Campbell P, Amstutz HC, Jiranek WA, Onyike A, Pombar XF, Jacobs JJ. 2014. Metal ion levels in maternal and placental blood after metal-on-metal total hip arthroplasty. Am J Orthop. 43:E304–E308.
  • Nygaard M, Bastholm L, Elling F, Soballe K, Borgwardt A. 2007. Can ultrastructural particle location predict aseptic loosening? A biopsy study of nonloose hip implants one year postoperative using three bearing material combinations. J Long Term Eff Med Implants. 17:321–334.
  • Ogunwale B, Schmidt-Ott A, Meek RM, Brewer JM. 2009. Investigating the immunologic effects of CoCr nanoparticles. Clin Orthop Relat Res. 467:3010–3016.
  • Pahuta M, Smolders JM, van Susante JL, Peck J, Kim PR, Beaule PE. 2016. Blood metal ion levels are not a useful test for adverse reactions to metal debris: a systematic review and meta-analysis. Bone Joint Res. 5:379–386.
  • Panichkul P, Fricka KB, Hopper RH, Jr, Engh CA. Jr. 2015. Greater trochanteric fragmentation after failed metal-on-metal hip arthroplasty. Orthopedics. 38:e447–e451.
  • Parry MC, Bhabra G, Sood A, Machado F, Cartwright L, Saunders M, Ingham E, Newson R, Blom AW, Case CP. 2010. Thresholds for indirect DNA damage across cellular barriers for orthopaedic biomaterials. Biomaterials. 31:4477–4483.
  • Paxton EW, Inacio MC, Namba RS, Love R, Kurtz SM. 2015. Metal-on-conventional polyethylene total hip arthroplasty bearing surfaces have a higher risk of revision than metal-on-highly crosslinked polyethylene: results from a US registry. Clin Orthop Relat Res. 473:1011–1021.
  • Perino G, Ricciardi BF, Jerabek SA, Martignoni G, Wilner G, Maass D, Goldring SR, Purdue PE. 2014. Implant based differences in adverse local tissue reaction in failed total hip arthroplasties: a morphological and immunohistochemical study. BMC Clin Pathol. 14:39.
  • Posada OM, Tate RJ, Grant MH. 2015. Effects of CoCr metal wear debris generated from metal-on-metal hip implants and Co ions on human monocyte-like U937 cells. Toxicol In Vitro. 29:271–280.
  • Post ZD, Orozco FR, Ong AC. 2013. Metal sensitivity after TKA presenting with systemic dermatitis and hair loss. Orthopedics. 36:e525–e528.
  • Prokopovich P. 2014. Interactions between mammalian cells and nano- or micro-sized wear particles: physico-chemical views against biological approaches. Adv Colloid Interface Sci. 213:36–47.
  • Purdue PE. 2008. Alternative macrophage activation in periprosthetic osteolysis. Autoimmunity. 41:212–217.
  • Rakow A, Schoon J, Dienelt A, John T, Textor M, Duda G, Perka C, Schulze F, Ode A. 2016. Influence of particulate and dissociated metal-on-metal hip endoprosthesis wear on mesenchymal stromal cells in vivo and in vitro. Biomaterials. 98:31–40.
  • Ramage SC, Urban NH, Jiranek WA, Maiti A, Beckman MJ. 2007. Expression of RANKL in osteolytic membranes: association with fibroblastic cell markers. J Bone Joint Surg Am. 89:841–848.
  • Rana SV. 2008. Metals and apoptosis: recent developments. J Trace Elem Med Biol. 22:262–284.
  • Reddy A, Caicedo MS, Samelko L, Jacobs JJ, Hallab NJ. 2014. Implant debris particle size affects serum protein adsorption which may contribute to particle size-based bioreactivity differences. J Long Term Eff Med Implants. 24:77–88.
  • Ricciardi BF, Nocon AA, Jerabek SA, Wilner G, Kaplowitz E, Goldring SR, Purdue PE, Perino G. 2016. Histopathological characterization of corrosion product associated adverse local tissue reaction in hip implants: a study of 285 cases. BMC Clin Pathol. 16:3. eCollection 2016.
  • Rosengren BE. 2012. Metal-on-metal hip implants and the risk of cancer. BMJ. 345:e4605.
  • Rovetta F, Stacchiotti A, Faggi F, Catalani S, Apostoli P, Fanzani A, Aleo MF. 2013. Cobalt triggers necrotic cell death and atrophy in skeletal C2C12 myotubes. Toxicol Appl Pharmacol. 271:196–205.
  • Sabokbar A, Mahoney DJ, Hemingway F, Athanasou NA. 2016. Non-canonical (RANKL-independent) pathways of osteoclast differentiation and their role in musculoskeletal diseases. Clin Rev Allergy Immunol. 51:16–26.
  • Sarhadi VK, Parkkinen J, Reito A, Nieminen J, Porkka N, Wirtanen T, Laitinen M, Eskelinen A, Knuutila S. 2015. Genetic alterations in periprosthetic soft-tissue masses from patients with metal-on-metal hip replacement. Mutat Res. 781:1–6.
  • Savarino L, Cadossi M, Chiarello E, Baldini N, Giannini S. 2013. Do ion levels in metal-on-metal hip resurfacing differ from those in metal-on-metal THA at long-term followup? Clin Orthop Relat Res. 471:2964–2971.
  • Savarino L, Cadossi M, Chiarello E, Fotia C, Greco M, Baldini N, Giannini S. 2014. How do metal ion levels change over time in hip resurfacing patients? A cohort study. Sci World J. 2014:291925.
  • Savarino L, Fotia C, Roncuzzi L, Greco M, Cadossi M, Baldini N, Giannini S. 2015. Does chronic raise of metal ion levels induce oxidative DNA damage and hypoxia-like response in patients with metal-on-metal hip resurfacing? J Biomed Mater Res B Appl Biomater. 105:460–466.
  • Savarino L, Granchi D, Ciapetti G, Cenni E, Nardi Pantoli A, Rotini R, Veronesi CA, Baldini N, Giunti A. 2002. Ion release in patients with metal-on-metal hip bearings in total joint replacement: a comparison with metal-on-polyethylene bearings. J Biomed Mater Res. 63:467–474.
  • Savarino L, Granchi D, Ciapetti G, Stea S, Donati ME, Zinghi G, Fontanesi G, Rotini R, Montanaro L. 1999. Effects of metal ions on white blood cells of patients with failed total joint arthroplasties. J Biomed Mater Res. 47:543–550.
  • Savarino L, Padovani G, Ferretti M, Greco M, Cenni E, Perrone G, Greco F, Baldini N, Giunti A. 2008. Serum ion levels after ceramic-on-ceramic and metal-on-metal total hip arthroplasty: 8-year minimum follow-up. J Orthop Res. 26:1569–1576.
  • Scharf B, Clement CC, Zolla V, Perino G, Yan B, Elci SG, Purdue E, Goldring S, Macaluso F, Cobelli N, et al. 2014. Molecular analysis of chromium and cobalt-related toxicity. Sci Rep. 4:5729.
  • Schmalzried TP, Peters PC, Maurer BT, Bragdon CR, Harris WH. 1996. Long-duration metal-on-metal total hip arthroplasties with low wear of the articulating surfaces. J Arthroplasty. 11:322–331.
  • Sehatzadeh S, Kaulback K, Levin L. 2012. Metal-on-metal hip resurfacing arthroplasty: an analysis of safety and revision rates. Ont Health Technol Assess Ser. 12:1–63.
  • Sidaginamale RP, Joyce TJ, Bowsher JG, Lord JK, Avery PJ, Natu S, Nargol AV, Langton DJ. 2016. The clinical implications of metal debris release from the taper junctions and bearing surfaces of metal-on-metal hip arthroplasty: joint fluid and blood metal ion concentrations. Bone Joint J. 98-B:925–933.
  • Silverman EJ, Ashley B, Sheth NP. 2016. Metal-on-metal total hip arthroplasty: is there still a role in 2016? Curr Rev Musculoskelet Med. 9:93–96.
  • Simoes TA, Brown AP, Milne SJ, Brydson RMD. 2015. Bovine serum albumin binding to CoCrMo nanoparticles and the influence on dissolution. J Phys: Conf Ser. 644:012039.
  • Simonsen LO, Harbak H, Bennekou P. 2012. Cobalt metabolism and toxicology—a brief update. Sci Total Environ. 432:210–215.
  • Singh G, Nuechtern JV, Meyer H, Fiedler GM, Awiszus F, Junk-Jantsch S, Bruegel M, Pflueger G, Lohmann CH. 2015. Particle characterisation and cytokine expression in failed small-diameter metal-on-metal total hip arthroplasties. Bone Joint J. 97-B:917–923.
  • Smith AJ, Dieppe P, Howard PW, Blom AW, National Joint Registry for England and Wales. 2012. Failure rates of metal-on-metal hip resurfacings: analysis of data from the National Joint Registry for England and Wales. Lancet. 380:1759–1766.
  • Stea S, Visentin M, Granchi D, Ciapetti G, Donati ME, Sudanese A, Zanotti C, Toni A. 2000. Cytokines and osteolysis around total hip prostheses. Cytokine. 12:1575–1579.
  • Stea S, Visentin M, Granchi D, Savarino L, Dallari D, Gualtieri G, Rollo G, Toni A, Pizzoferrato A, Montanaro L. 2000. Sister chromatid exchange in patients with joint prostheses. J Arthroplasty. 15:772–777.
  • Stohs SJ, Bagchi D. 1995. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 18:321–336.
  • Su SL, Koch CN, Nguyen TM, Burket JC, Wright TM, Westrich GH. 2017. Retrieval analysis of neck-stem coupling in modular hip prostheses. J Arthroplasty. 32:2301–2306.
  • Teo WZW, Schalock PC. 2017. Metal hypersensitivity reactions to orthopedic implants. Dermatol Ther (Heidelb). 7:53–64.
  • Thomas P, von der Helm C, Schopf C, Mazoochian F, Frommelt L, Gollwitzer H, Schneider J, Flaig M, Krenn V, Thomas B, et al. 2015. Patients with intolerance reactions to total knee replacement: combined assessment of allergy diagnostics, periprosthetic histology, and peri-implant cytokine expression pattern. Biomed Res Int. 2015:910156.
  • Thomas P, von der Helm C, Schopf C, Thomsen M, Frommelt L, Schneider J, Flaig M, Krenn V, Mazoochian F, Burkhard S. 2012. Periimplant histology and cytokine pattern in metal-allergic knee arthroplasty patients with improvement after revision with hypoallergenic materials. Semin Arthroplasty. 23:268–272.
  • Tipper JL, Hatton A, Nevelos JE, Ingham E, Doyle C, Streicher R, Nevelos AB, Fisher J. 2002. Alumina-alumina artificial hip joints. Part II: characterisation of the wear debris from in vitro hip joint simulations. Biomaterials. 23:3441–3448.
  • Tiusanen H, Makela K, Kiilunen M, Sarantsin P, Sipola E, Pesola M. 2013. The effect of different bearing surfaces on metal ion levels in urine following 28 mm metal-on-metal and 28 mm metal-on-polyethylene total hip arthroplasty. Scand J Surg. 102:197–203.
  • Tolan NV, Sierra RJ, Moyer TP. 2015. Evidence against implant-derived cobalt toxicity: case report and retrospective study of serum cobalt concentrations in an orthopedic implant population. Clin Biochem. 48:130–134.
  • Tower SS. 2010. Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: a case report. J Bone Joint Surg Am. 92:2847–2851.
  • Traina F, De Clerico M, Biondi F, Pilla F, Tassinari E, Toni A. 2009. Sex differences in hip morphology: is stem modularity effective for total hip replacement? J Bone Joint Surg Am. 91 Suppl 6:121–128.
  • Tyson-Capper AJ, Lawrence H, Holland JP, Deehan DJ, Kirby JA. 2013. Metal-on-metal hips: cobalt can induce an endotoxin-like response. Ann Rheum Dis. 72:460–461.
  • U.S. Food and Drug Administration. Metal-on-Metal Hip Implants; [accessed 2016 May 04]. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/default.htm. http://www.webcitation.org/6hFeYMQ93.
  • Van Der Straeten C, Grammatopoulos G, Gill HS, Calistri A, Campbell P, De Smet KA. 2013. The 2012 Otto Aufranc Award: the interpretation of metal ion levels in unilateral and bilateral hip resurfacing. Clin Orthop Relat Res. 471:377–385.
  • van der Weegen W, Smolders JM, Sijbesma T, Hoekstra HJ, Brakel K, van Susante JL. 2013. High incidence of pseudotumours after hip resurfacing even in low risk patients; results from an intensified MRI screening protocol. Hip Int. 23:243–249.
  • VanOs R, Lildhar LL, Lehoux EA, Beaule PE, Catelas I. 2014. In vitro macrophage response to nanometer-size chromium oxide particles. J Biomed Mater Res Part B Appl Biomater. 102:149–159.
  • Vasudevan A, DiCarlo EF, Wright T, Chen D, Figgie MP, Goldring SR, Mandl LA. 2012. Cellular response to prosthetic wear debris differs in patients with and without rheumatoid arthritis. Arthritis Rheum. 64:1005–1014.
  • Vendittoli PA, Mottard S, Roy AG, Dupont C, Lavigne M. 2007. Chromium and cobalt ion release following the Durom high carbon content, forged metal-on-metal surface replacement of the hip. J Bone Joint Surg Br. 89:441–448.
  • Vendittoli PA, Riviere C, Roy AG, Barry J, Lusignan D, Lavigne M. 2013. Metal-on-metal hip resurfacing compared with 28-mm diameter metal-on-metal total hip replacement: a randomised study with six to nine years' follow-up. Bone Joint J. 95-B:1464–1473.
  • Vertullo CJ, Lewis PL, Graves S, Kelly L, Lorimer M, Myers P. 2017. Twelve-year outcomes of an oxinium total knee replacement compared with the same cobalt–chromium design: an analysis of 17,577 prostheses from the Australian Orthopaedic Association National Joint Replacement Registry. J Bone Joint Surg Am. 99:275–283.
  • Vierra BM, Blumenthal SR, Amanatullah DF. 2017. Modularity in total hip arthroplasty: benefits, risks, mechanisms, diagnosis, and management. Orthopedics. 9:1–12.
  • Visuri T, Borg H, Pulkkinen P, Paavolainen P, Pukkala E. 2010. A retrospective comparative study of mortality and causes of death among patients with metal-on-metal and metal-on-polyethylene total hip prostheses in primary osteoarthritis after a long-term follow-up. BMC Musculoskelet Disord. 11:78–2474-11-78.
  • Visuri T, Pukkala E, Pulkkinen P, Paavolainen P. 2003. Decreased cancer risk in patients who have been operated on with total hip and knee arthroplasty for primary osteoarthrosis: a meta-analysis of 6 Nordic cohorts with 73,000 patients. Acta Orthop Scand. 74:351–360.
  • Wagner P, Olsson H, Lidgren L, Robertsson O, Ranstam J. 2011. Increased cancer risks among arthroplasty patients: 30 year follow-up of the Swedish Knee Arthroplasty Register. Eur J Cancer. 47:1061–1071.
  • Wang JY, Tsukayama DT, Wicklund BH, Gustilo RB. 1996. Inhibition of T and B cell proliferation by titanium, cobalt, and chromium: role of IL-2 and IL-6. J Biomed Mater Res. 32:655–661.
  • Wang JY, Wicklund BH, Gustilo RB, Tsukayama DT. 1997. Prosthetic metals impair murine immune response and cytokine release in vivo and in vitro. J Orthop Res. 15:688–699.
  • Wang Z, Liu N, Liu K, Zhou G, Gan J, Wang Z, Shi T, He W, Wang L, Guo T, et al. 2015. Autophagy mediated CoCrMo particle-induced peri-implant osteolysis by promoting osteoblast apoptosis. Autophagy. 11:2358–2369.
  • Wawrzynski J, Gil JA, Goodman AD, Waryasz GR. 2017. Hypersensitivity to orthopedic implants: a review of the literature. Rheumatol Ther. 4:45–56.
  • Willert HG, Buchhorn GH, Fayyazi A, Flury R, Windler M, Koster G, Lohmann CH. 2005. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J Bone Joint Surg Am. 87:28–36.
  • Williams DH, Greidanus NV, Masri BA, Duncan CP, Garbuz DS. 2011. Prevalence of pseudotumor in asymptomatic patients after metal-on-metal hip arthroplasty. J Bone Joint Surg Am. 93:2164–2171.
  • Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. 2005. Mediation of biomaterial–cell interactions by adsorbed proteins: a review. Tissue Eng. 11:1–18.
  • Wimmer MA, Fischer A, Büscher R, Pourzal R, Sprecher C, Hauert R, Jacobs JJ. 2010. Wear mechanisms in metal-on-metal bearings: the importance of tribochemical reaction layers. J Orthop Res. 28:436–443.
  • Wimmer MA, Laurent MP, Mathew MT, Nagelli C, Liao Y, Marks LD, Jacobs JJ, Fischer A. 2015. The effect of contact load on CoCrMo wear and the formation and retention of tribofilms. Wear. 332–333:643–649.
  • Wu W, Liu P, Li J. 2012. Necroptosis: an emerging form of programmed cell death. Crit Rev Oncol Hematol. 82:249–258.
  • Wyles CC, Van Demark RE III, Sierra RJ, Trousdale RT. 2014. High rate of infection after aseptic revision of failed metal-on-metal total hip arthroplasty. Clin Orthop Relat Res. 472:509–516.
  • Xia Z, Kwon YM, Mehmood S, Downing C, Jurkschat K, Murray DW. 2011. Characterization of metal-wear nanoparticles in pseudotumor following metal-on-metal hip resurfacing. Nanomedicine. 7:674–681.
  • Xia Z, Ricciardi BF, Liu BAZ, von Ruhland C, Ward M, Lord A, Hughes L, Goldring SR, Purdue E, Murray D, et al. 2017. Nano-analyses of wear particles from metal-on-metal and non-metal-on-metal dual modular neck hip arthroplasty. Nanomedicine. 13:1205–1217.
  • Yadav J, Samelko L, Gilvar P, McAllister K, Hallab NJ. 2013. Osteoclasts lose innate inflammatory reactivity to metal and polymer implant debris compared to monocytes/macrophages. Open Orthop J. 7:605–613.
  • Zagra L. 2017. Advances in hip arthroplasty surgery: what is justified? EFORT Open Rev. 2:171–178.
  • Zeng Y, Feng W. 2013. Metal allergy in patients with total hip replacement: a review. J Int Med Res. 41:247–252.
  • Zhao H, Jaffer T, Eguchi S, Wang Z, Linkermann A, Ma D. 2015. Role of necroptosis in the pathogenesis of solid organ injury. Cell Death Dis. 6:e1975.
  • Ziaee H, Daniel J, Datta AK, Blunt S, McMinn DJ. 2007. Transplacental transfer of cobalt and chromium in patients with metal-on-metal hip arthroplasty: a controlled study. J Bone Joint Surg Br. 89:301–305.
  • Zijlstra WP, van der Veen HC, van den Akker-Scheek I, Zee MJ, Bulstra SK, van Raay JJ. 2014. Acetabular bone density and metal ions after metal-on-metal versus metal-on-polyethylene total hip arthroplasty; short-term results. Hip Int. 24:136–143.
  • Zywiel MG, Cherian JJ, Banerjee S, Cheung AC, Wong F, Butany J, Gilbert C, Overgaard C, Syed K, Jacobs JJ, et al. 2016. Systemic cobalt toxicity from total hip arthroplasties: review of a rare condition. Part 2. Measurement, risk factors, and step-wise approach to treatment. Bone Joint J. 98-B:14–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.